Infectious diarrhea Medical Services in China

Infectious diarrhea is an acute gastrointestinal disorder characterized by frequent, loose, or watery stools caused by pathogenic microorganisms—including bacteria (e.g., Salmonella, Campylobacter, Shigella, Escherichia coli), viruses (e.g., norovirus, rotavirus, adenovirus), and parasites (e.g., Giardia lamblia, Cryptosporidium)—that invade the intestinal mucosa or produce enterotoxins. Pathogenesis involves either direct mucosal invasion leading to inflammation and epithelial damage, or toxin-mediated disruption of ion transport (e.g., cholera toxin activating adenylate cyclase → chloride secretion → osmotic water loss). In some cases, post-infectious complications such as reactive arthritis, Guillain-Barré syndrome (linked to Campylobacter), or irritable bowel syndrome may arise. Globally, infectious diarrhea remains a leading cause of morbidity and mortality—especially among children under five—accounting for an estimated 1.6 million deaths annually, with over 90% occurring in low- and middle-income countries. In China, incidence peaks during summer and early autumn due to warmer temperatures favoring bacterial proliferation and increased consumption of raw or undercooked foods. Risk factors include poor sanitation, inadequate hand hygiene, contaminated food/water, travel to endemic regions, immunocompromised status (e.g., HIV, chemotherapy), antibiotic use (predisposing to Clostridioides difficile infection), and age extremes (infants and elderly). While most cases are self-limiting, severe dehydration, electrolyte imbalances (hypokalemia, metabolic acidosis), acute kidney injury, and sepsis can occur—particularly in vulnerable populations. Beyond physical consequences, infectious diarrhea significantly impairs quality of life: it disrupts work and school attendance, causes anxiety about recurrence or transmission, strains caregiver resources, and may lead to nutritional deficits and growth faltering in children. Chronic or recurrent episodes may erode confidence in daily activities, reduce social engagement, and contribute to long-term gastrointestinal hypersensitivity. Early recognition, appropriate rehydration (oral or intravenous), targeted antimicrobial therapy when indicated (e.g., for dysentery or systemic infection), and supportive care remain cornerstones of management. Prevention emphasizes food safety education, access to clean water, vaccination (e.g., rotavirus vaccine), and antimicrobial stewardship to curb resistance.

Infectious diarrhea is an acute or subacute gastrointestinal disorder characterized by increased stool frequency, volume, or liquidity resulting from infection of the intestinal mucosa by pathogenic microorganisms. It remains a leading cause of morbidity and mortality worldwide, particularly among young children, immunocompromised individuals, and travelers to endemic regions. The primary etiologies fall into three major categories: bacterial, viral, and parasitic agents. Bacterial causes include enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni, Salmonella enterica serovars (e.g., Typhimurium, Enteritidis), Shigella spp., Clostridioides difficile (particularly in antibiotic-associated cases), and less commonly Yersinia enterocolitica and Aeromonas hydrophila. Viral pathogens predominate in pediatric populations and institutional outbreaks; norovirus is the most frequent cause globally across all age groups, followed by rotavirus (despite widespread vaccination, still relevant in under-immunized cohorts), adenovirus (serotypes 40 and 41), and astrovirus. Protozoan parasites—especially Giardia lamblia (duodenalis), Cryptosporidium parvum/hominis, and Cyclospora cayetanensis—are common in settings with inadequate water sanitation and among immunocompromised hosts, such as those with HIV/AIDS or on chronic immunosuppressive therapy. Less frequently, microsporidia (e.g., Enterocytozoon bieneusi) may cause persistent watery diarrhea in severely immunocompromised patients.

Triggers of infectious diarrhea are predominantly exogenous and relate to exposure routes. Ingestion of contaminated food or water is the principal transmission mechanism—commonly associated with undercooked poultry (Campylobacter, Salmonella), raw shellfish (norovirus, Vibrio), unpasteurized dairy or juice (E. coli O157:H7, Campylobacter), and inadequately washed produce (Cyclospora, Cryptosporidium). Person-to-person transmission occurs via fecal-oral spread, especially in daycare centers, nursing homes, and healthcare facilities (notably for norovirus and C. difficile). Outbreaks are frequently linked to environmental contamination of communal water supplies, recreational water venues (e.g., swimming pools), or improper hand hygiene after toileting or diaper changing.

Risk factors are multifactorial and interrelated. Age is a critical determinant: infants and young children exhibit heightened susceptibility due to immature mucosal immunity, lower gastric acidity, and frequent hand-to-mouth behavior. Elderly individuals face increased risk owing to immunosenescence, comorbidities, polypharmacy (especially proton pump inhibitors and antibiotics), and institutionalization. Immunocompromised states—including HIV infection with CD4+ counts <200/μL, solid organ or hematopoietic stem cell transplantation, and treatment with corticosteroids or biologic immunomodulators—predispose to severe, prolonged, or atypical presentations (e.g., disseminated salmonellosis, cryptosporidiosis refractory to standard therapy). Travel to resource-limited regions (e.g., Latin America, Africa, South Asia) significantly elevates risk, particularly during the first two weeks, due to exposure to region-specific pathogens and variable food/water safety standards (‘traveler’s diarrhea’). Other clinical risk factors include recent antibiotic use (strongly associated with C. difficile infection), gastric acid suppression (increasing vulnerability to acid-sensitive organisms like Salmonella and E. coli), and underlying gastrointestinal disorders such as inflammatory bowel disease (IBD), which may impair barrier function and alter microbiota composition.

Genetic factors play a modest but increasingly recognized role. Polymorphisms in innate immune response genes—including TLR4 (affecting LPS recognition), NOD2/CARD15 (implicated in Crohn’s disease and altered bacterial sensing), and FUT2 (the ‘secretor status’ gene influencing norovirus susceptibility)—modulate individual vulnerability. Non-secretors (homozygous for FUT2 null alleles) demonstrate relative resistance to certain norovirus genotypes but may be more susceptible to other enteric pathogens. HLA class II variants have been associated with differential immune responses to rotavirus and Giardia. However, no single high-penetrance Mendelian disorder directly causes infectious diarrhea; rather, genetic background contributes to quantitative differences in host defense efficiency.

Environmental factors are paramount in disease epidemiology. Poor sanitation infrastructure, lack of access to safe drinking water, inadequate sewage disposal, and overcrowded living conditions dramatically increase transmission risk—especially for waterborne pathogens like Cryptosporidium and hepatitis E virus (which can present with diarrheal prodrome). Climate variables influence pathogen survival and outbreak dynamics: warmer temperatures promote bacterial proliferation (e.g., Vibrio species in coastal waters), while heavy rainfall and flooding facilitate fecal contamination of water sources. Seasonality is evident—rotavirus peaks in winter months in temperate zones, whereas enteric adenoviruses and some bacterial infections show less pronounced seasonality. Socioeconomic determinants—including poverty, limited health literacy, and reduced access to timely diagnostics and rehydration therapy—compound biological risks and contribute to disparities in outcomes. Finally, global travel, food globalization, and antimicrobial overuse in agriculture and human medicine drive the emergence and spread of multidrug-resistant enteric pathogens, representing a growing public health challenge for gastroenterologists managing complex or recurrent infectious diarrhea.

Infectious diarrhea is an acute gastrointestinal infection caused by bacterial, viral, parasitic, or toxin-mediated pathogens, commonly presenting in the Department of Gastroenterology. Its clinical manifestations vary by etiologic agent, host immunity, and disease severity, but follow a characteristic temporal evolution. Early symptoms—typically emerging within hours to 3 days post-exposure—include low-grade fever (37.5–38.5°C), malaise, anorexia, and nonspecific abdominal discomfort, often localized to the epigastrium or periumbilical region. Nausea is frequently reported before the onset of diarrhea; vomiting may occur early, especially with norovirus, rotavirus, or Staphylococcus aureus enterotoxin exposure. In bacterial infections such as Campylobacter jejuni or Shigella spp., patients may experience prodromal myalgias and headache. Importantly, early symptom severity does not reliably predict progression: some individuals with mild initial complaints rapidly develop high-volume watery diarrhea, while others with prominent vomiting (e.g., in viral gastroenteritis) may have relatively modest stool frequency initially.

Typical symptoms define the active phase and usually peak within 24–72 hours. Profuse, watery diarrhea is the hallmark—often exceeding 3 loose or liquid stools per day, with volumes ranging from 200 mL to >1 L daily depending on pathogen virulence and host factors. Enterotoxigenic Escherichia coli (ETEC) and Vibrio cholerae induce secretory diarrhea via cyclic AMP–mediated chloride secretion, resulting in painless, rice-water stools without significant inflammation. In contrast, invasive pathogens—including Shigella flexneri, Salmonella enterica serovar Typhimurium, Campylobacter jejuni, and enteroinvasive E. coli (EIEC)—trigger inflammatory diarrhea characterized by frequent small-volume stools containing blood, mucus, or pus (dysentery). These are typically accompanied by crampy, colicky lower abdominal pain, tenesmus, and urgency. Fever ≥38.5°C is common in invasive infections and correlates with systemic cytokine release. Duration varies: viral cases (norovirus, rotavirus, adenovirus) usually resolve within 1–3 days; bacterial infections persist 4–7 days untreated; and parasitic causes (e.g., Giardia lamblia, Cryptosporidium parvum) may cause prolonged (>14-day), intermittent, or relapsing diarrhea with steatorrhea and bloating.

Accompanying symptoms reflect systemic involvement and extraintestinal effects. Dehydration manifests as orthostatic hypotension, tachycardia, dry mucous membranes, decreased skin turgor, and reduced urine output—particularly critical in infants, elderly, and immunocompromised patients. Electrolyte disturbances include hypokalemia (causing muscle weakness, arrhythmias), metabolic acidosis (from bicarbonate loss and lactic acidosis), and hyponatremia (especially with excessive free-water replacement). Abdominal distension may signal ileus or toxic megacolon in severe Clostridioides difficile infection. Arthralgias and reactive arthritis (e.g., post-Shigella or Campylobacter) can emerge 1–4 weeks after resolution. Guillain-Barré syndrome—a rare but life-threatening autoimmune polyneuropathy—is associated with antecedent Campylobacter infection. Hemolytic uremic syndrome (HUS), marked by microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury, is classically linked to Shiga-toxin–producing E. coli (STEC), notably O157:H7.

Complications arise from direct pathogen effects, immune dysregulation, or treatment-related factors. Severe dehydration may precipitate acute renal failure, shock, or ischemic colitis. Pseudomembranous colitis—characterized by endoscopic yellow-white plaques and histologic neutrophilic infiltration—is a complication of antibiotic-associated C. difficile infection. Chronic sequelae include post-infectious irritable bowel syndrome (PI-IBS), occurring in ~10% of patients after acute infectious diarrhea, with persistent abdominal pain and altered bowel habits lasting >6 months. Malabsorption syndromes may follow giardiasis or tropical sprue–like presentations. Rarely, bacteremia occurs with Salmonella typhi (typhoid fever), non-typhoidal Salmonella in immunocompromised hosts, or invasive E. coli.

Diagnosis relies on clinical assessment combined with targeted laboratory testing. Stool culture remains gold standard for bacterial pathogens (Salmonella, Shigella, Campylobacter, Yersinia), though sensitivity declines after antibiotic initiation. Multiplex PCR panels detect DNA/RNA of common viruses (rotavirus, norovirus, astrovirus), bacteria (Campylobacter, Salmonella, Shiga-toxin genes), and parasites (Giardia, Cryptosporidium, Entamoeba histolytica) with high sensitivity and rapid turnaround (<2 hours). Enzyme immunoassays (EIAs) for C. difficile toxins A/B or glutamate dehydrogenase (GDH) plus toxin testing are recommended for suspected antibiotic-associated diarrhea. Microscopy with modified acid-fast staining identifies Cryptosporidium and Cyclospora; ova-and-parasite (O&P) examination remains useful for less common protozoa. Blood tests—including CBC (leukocytosis, anemia, thrombocytopenia in HUS), electrolytes, renal function, lactate, and CRP—assess severity and complications. In select cases (e.g., persistent diarrhea, immunosuppression), colonoscopy with biopsy may reveal histopathologic features such as crypt abscesses (invasive colitis) or villous atrophy (chronic giardiasis).

Differential diagnosis must exclude non-infectious mimics. Inflammatory bowel disease (IBD) flares present with chronic or recurrent bloody diarrhea, weight loss, and extraintestinal manifestations—but lack acute febrile prodrome and often show elevated fecal calprotectin without pathogen detection. Ischemic colitis typically affects older adults with cardiovascular risk factors and presents with sudden-onset abdominal pain and hematochezia, often sparing the rectum. Medication-induced diarrhea (e.g., antibiotics, metformin, laxatives, proton pump inhibitors) requires careful drug history review. Endocrine disorders—including hyperthyroidism (tachycardia, weight loss, heat intolerance) and Addison’s disease (hypotension, hyponatremia, hyperkalemia)—may manifest with chronic diarrhea. Microscopic colitis (lymphocytic or collagenous) predominantly affects older women with chronic watery diarrhea unresponsive to fasting, normal colonoscopy, and diagnostic histology. Functional diarrhea and IBS-D feature chronic symptoms without alarm features (fever, nocturnal diarrhea, weight loss, bleeding) and negative infectious workup. Finally, food protein–induced enterocolitis syndrome (FPIES) in infants mimics sepsis with vomiting and lethargy but lacks fever or leukocytosis and resolves with allergen avoidance. Accurate differentiation hinges on meticulous history (travel, food exposure, antibiotics, immunosuppression), physical exam (hydration status, abdominal tenderness, rash), and judicious use of diagnostics to avoid unnecessary empiric antimicrobial therapy.

Infectious diarrhea—defined as acute or subacute diarrheal illness caused by bacterial, viral, parasitic, or toxin-mediated pathogens—is a common gastrointestinal disorder managed primarily within gastroenterology departments. In China, the Digestive Medicine Department (Gastroenterology) adopts an evidence-based, stratified approach integrating conservative management, targeted pharmacotherapy, and rare surgical intervention when complications arise. Treatment is tailored to pathogen identification (when feasible), clinical severity, host factors (e.g., age, immunocompromise, comorbidities), and epidemiologic context.

Conservative treatment forms the cornerstone of management for most cases—particularly mild-to-moderate infectious diarrhea. Oral rehydration therapy (ORT) remains the single most effective life-saving intervention. The World Health Organization–recommended low-osmolarity oral rehydration solution (ORS) containing 75 mmol/L sodium, 75 mmol/L glucose, 20 mmol/L potassium, and 10 mmol/L citrate is widely used in Chinese hospitals and community health centers. ORT restores electrolyte deficits, corrects mild-to-moderate dehydration, and reduces stool volume and duration. For infants and young children, continued breastfeeding or age-appropriate lactose-tolerant formula is strongly encouraged; dietary resumption with easily digestible foods (e.g., rice, bananas, applesauce, toast—'BRAT' diet adjunct) is initiated within 4–6 hours of rehydration, avoiding fasting. Probiotics—including Lactobacillus rhamnosus GG, Saccharomyces boulardii, and Bifidobacterium triple viable capsules (a standardized formulation approved by China’s NMPA)—are routinely prescribed for 5–7 days in pediatric and adult patients to shorten diarrheal duration by approximately 24 hours and reduce persistent diarrhea risk. Zinc supplementation (10–20 mg elemental zinc daily for 10–14 days) is standard in children under five, per national guidelines, due to its proven efficacy in reducing recurrence and severity.

Pharmacologic intervention is selective—not routine. Antibiotics are reserved for specific indications: confirmed or highly suspected invasive bacterial pathogens (e.g., Shigella, Campylobacter jejuni, invasive Escherichia coli, Salmonella in high-risk groups), systemic toxicity (fever >38.5°C, tachycardia, leukocytosis), immunosuppression, or prolonged symptoms (>72 hours with worsening). First-line agents in China include fluoroquinolones (e.g., levofloxacin 500 mg once daily for adults, contraindicated in children <18 years) and azithromycin (500 mg daily × 3 days), particularly for Campylobacter or suspected macrolide-sensitive strains. For Clostridioides difficile infection (CDI), vancomycin (125 mg orally four times daily) or fidaxomicin (200 mg twice daily) is administered, with fecal microbiota transplantation (FMT) increasingly available at tertiary centers for recurrent CDI. Antiparasitics—such as nitazoxanide (500 mg twice daily × 3 days for Cryptosporidium or Giardia) or tinidazole (2 g single dose for Giardia)—are deployed following microscopic or PCR-confirmed diagnosis. Antimotility agents (e.g., loperamide) are cautiously used only in non-febrile, non-dysenteric adults without systemic signs; they are contraindicated in suspected Shiga-toxin–producing E. coli (STEC) or C. difficile due to risk of toxic megacolon or HUS. Antiemetics (e.g., ondansetron) may be considered for severe nausea/vomiting impeding ORT adherence.

Surgical treatment is exceedingly rare and strictly limited to life-threatening complications. These include toxic megacolon (typically secondary to C. difficile or severe ulcerative colitis mimicking infection), perforation, fulminant colitis unresponsive to maximal medical therapy, or ischemic bowel secondary to hypovolemic shock. Emergency colectomy—often subtotal with end ileostomy—may be required in refractory toxic megacolon with hemodynamic instability or radiographic evidence of free air. Laparoscopic exploration is increasingly utilized in advanced centers for diagnostic clarification in atypical presentations. Surgical decision-making involves multidisciplinary collaboration between gastroenterologists, colorectal surgeons, and critical care specialists, with emphasis on preoperative optimization of fluid, electrolyte, and septic parameters.

China offers distinct advantages in infectious diarrhea management. First, the nationwide integrated surveillance system—led by the Chinese Center for Disease Control and Prevention (China CDC)—enables rapid pathogen detection via multiplex PCR panels (e.g., GI Pathogen Panels detecting 22+ bacteria, viruses, and parasites) within 4–6 hours in Class III-A hospitals. Second, standardized clinical pathways endorsed by the Chinese Society of Gastroenterology ensure consistent application of ORT, antibiotic stewardship protocols, and probiotic regimens across urban and rural settings. Third, China’s robust domestic pharmaceutical industry supplies high-quality, affordable generic antibiotics, zinc, ORS, and probiotics—reducing treatment delays and out-of-pocket costs. Fourth, telemedicine platforms (e.g., WeDoctor, Ping An Good Doctor) facilitate remote triage and ORT guidance for rural populations, improving early intervention. Finally, large-scale public health initiatives—including sanitation infrastructure upgrades, food safety enforcement (e.g., 'Food Safety Law' implementation), and nationwide handwashing campaigns—have contributed to a 35% decline in all-cause diarrheal mortality among children under five since 2010.

Recovery advice emphasizes sustained hydration, nutritional rehabilitation, and infection prevention. Patients should continue oral fluids (water, diluted fruit juices, clear broths) until stool frequency normalizes—typically 48–72 hours after symptom resolution. A gradual return to balanced nutrition—including lean protein, complex carbohydrates, and soluble fiber (e.g., oats, cooked carrots)—is advised over 3–5 days; high-fat, spicy, or lactose-rich foods should be avoided for ≥7 days post-recovery, especially if lactase deficiency is suspected. Hand hygiene (soap-and-water washing for ≥20 seconds, especially after toileting and before eating) and safe food handling (thorough cooking of meats, avoidance of raw shellfish, refrigeration of leftovers <2 hours) are critical to prevent reinfection and household transmission. Household contacts should disinfect surfaces with chlorine-based solutions (≥1000 ppm). Follow-up is recommended if symptoms persist beyond 7 days, recur within 2 weeks, or if red flags emerge—including hematochezia, fever >39°C, severe abdominal pain, or signs of dehydration (e.g., oliguria, dizziness, sunken eyes). Vaccination counseling (e.g., rotavirus vaccine for infants, typhoid conjugate vaccine for travelers) is integrated into discharge planning in endemic regions. With timely, appropriate management, >95% of uncomplicated infectious diarrhea cases resolve fully within one week without sequelae.